<DOC>
	<DOCNO>NCT00970229</DOCNO>
	<brief_summary>The underlying goal study ass [ 123I ] MNI-420 SPECT image tool detect A2aR density brain PD HD research participant compare similarly age healthy subject .</brief_summary>
	<brief_title>Evaluation 123IMNI-420 SPECT Marker Adenosine A2a Receptor PD , HD Healthy Subjects .</brief_title>
	<detailed_description>- To assess dynamic uptake washout [ 123I ] MNI-420 brain use single photon emission compute tomography ( SPECT ) Parkinson 's disease ( PD ) , Huntington 's disease ( HD ) , similarly age healthy subject potential image biomarker adenosine receptor type A2a ( A2aR ) brain - To acquire initial safety data follow injection [ 123I ] MNI-420</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Huntington Disease</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<criteria>Parkinson Subject Selection . Subjects clinical diagnosis PD recruit study . The following criterion meet inclusion PD subject study : The participant 30 year old . Written inform consent obtain . Participants clinical diagnosis Parkinson disease base UK Brain Bank Criteria For female , nonchild bear potential negative urine pregnancy test day [ 123I ] MNI420 injection . Huntington Disease Subject Selection . Subjects diagnosis HD recruit study . The following criterion meet inclusion HD subject study : The participant 18 year old . Written inform consent obtain . Participants clinical diagnosis symptomatic Huntington disease genetic confirmation Subject able provide inform consent judged investigator , assent obtain subject informed consent provide appropriate legal representative next kin . For female childbearing potential , negative urine pregnancy test day [ 123I ] MNI420 injection . Healthy Control Subject Selection . Healthy control subject neurological disease recruit study . The following criterion meet inclusion healthy control subject study : The participant 18 year old . Written inform consent obtain . Negative history neurological psychiatric illness base evaluation research physician . For female , nonchild bear potential negative urine blood pregnancy test day [ 123I ] MNI420 injection . Parkinson subject exclude participation follow reason : The subject clinically significant abnormal laboratory value and/or clinically significant unstable medical psychiatric illness The subject disorder may interfere drug absorption distribution , metabolism , excretion ( include significant gastrointestinal surgery ) . The subject evidence clinically significant gastrointestinal , cardiovascular , hepatic , renal , hematological , neoplastic , endocrine , alternative neurological , immunodeficiency , pulmonary , disorder disease . Clinically significant evidence vascular disease alternative neurologic disorder Pregnancy Huntington disease subject exclude participation follow reason : The subject clinically significant abnormal laboratory value and/or clinically significant unstable medical psychiatric illness . The subject disorder may interfere drug absorption distribution , metabolism , excretion ( include significant gastrointestinal surgery ) . The subject evidence clinically significant gastrointestinal , cardiovascular , hepatic , renal , hematological , neoplastic , endocrine , alternative neurological , immunodeficiency , pulmonary , disorder disease . Pregnancy Clinically significant evidence vascular disease alternative neurologic disorder Healthy control subject exclude participation follow reason : The subject clinically significant abnormal laboratory value and/or clinically significant unstable medical psychiatric illness . The subject disorder may interfere drug absorption distribution , metabolism , excretion ( include significant gastrointestinal surgery ) . The subject evidence clinically significant gastrointestinal , cardiovascular , hepatic , renal , hematological , neoplastic , endocrine , neurological , immunodeficiency , pulmonary , disorder disease . Pregnancy Clinically significant evidence vascular disease neurologic disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>